ID: ALA4206040

Max Phase: Preclinical

Molecular Formula: C9H9BClN5O5S

Molecular Weight: 345.53

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C(NCB(O)O)S(=O)(=O)c1cc(Cl)cc(-c2nnn[nH]2)c1

Standard InChI:  InChI=1S/C9H9BClN5O5S/c11-6-1-5(8-13-15-16-14-8)2-7(3-6)22(20,21)9(17)12-4-10(18)19/h1-3,18-19H,4H2,(H,12,17)(H,13,14,15,16)

Standard InChI Key:  DBGVEPOPIFWWLP-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 345.53

Molecular Weight (Monoisotopic): 345.0106

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. González-Bello C..  (2017)  Antibiotic adjuvants - A strategy to unlock bacterial resistance to antibiotics.,  27  (18): [PMID:28827113] [10.1016/j.bmcl.2017.08.027]

2. González-Bello C, Rodríguez D, Pernas M, Rodríguez Á, Colchón E..  (2020)  β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs.,  63  (5): [PMID:31663735] [10.1021/acs.jmedchem.9b01279]

Source

Source(1):

• Scientific Literature